Walter j. Paulus

Q: What Schools Are Affiliated With Walter j. Paulus

Walter j. Paulus is affiliated with the following schools: Maastricht University, Leiden University, University of Porto, University of Antwerp, Vrije Universiteit Amsterdam, Ruhr University Bochum, University of Groningen, Osaka University

Walter j. Paulus's AcademicInfluence.com Rankings

Walter j. Paulus

Medical

#2311

World Rank

#2728

Historical Rank

Cardiology

#209

World Rank

#214

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Walter j. Paulus Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Walter j. Paulus's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. (2007) (2589)
A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. (2013) (2422)
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. (2011) (959)
How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). (2019) (687)
Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap (2016) (673)
Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension (2008) (658)
Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure (2006) (612)
Cardiomyocyte Stiffness in Diastolic Heart Failure (2005) (504)
What Mechanisms Underlie Diastolic Dysfunction in Heart Failure? (2004) (478)
Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction (2012) (417)
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology (2018) (402)
Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. (1994) (397)
Ultrasound and Microbubble-Targeted Delivery of Macromolecules Is Regulated by Induction of Endocytosis and Pore Formation (2009) (378)
Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. (2015) (377)
B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. (2013) (375)
Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction. (2016) (369)
European Study Group on Diastolic Heart Failure (1998) (352)
Hypophosphorylation of the Stiff N2B Titin Isoform Raises Cardiomyocyte Resting Tension in Failing Human Myocardium (2009) (336)
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology (2009) (319)
New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes. (2014) (318)
Myocardial contractile response to nitric oxide and cGMP. (1996) (302)
Right Ventricular Diastolic Impairment in Patients With Pulmonary Arterial Hypertension (2013) (277)
Phosphodiesterase 9A Controls Nitric-oxide Independent cGMP and Hypertrophic Heart Disease (2015) (270)
Treatment of heart failure with normal ejection fraction: an inconvenient truth! (2010) (264)
Modification of Abnormal Left Ventricular Diastolic Properties by Nifedipine in Patients with Hypertrophic Cardiomyopathy (1982) (262)
Pioglitazone Improves Cardiac Function and Alters Myocardial Substrate Metabolism Without Affecting Cardiac Triglyceride Accumulation and High-Energy Phosphate Metabolism in Patients With Well-Controlled Type 2 Diabetes Mellitus (2009) (252)
Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model (2013) (249)
Aortic stenosis (2009) (247)
Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation (2016) (233)
Peripartum Cardiomyopathy as a Part of Familial Dilated Cardiomyopathy (2010) (215)
Opposite Effects of Training in Rats With Stable and Progressive Pulmonary Hypertension (2009) (211)
Diabetes Mellitus Worsens Diastolic Left Ventricular Dysfunction in Aortic Stenosis Through Altered Myocardial Structure and Cardiomyocyte Stiffness (2011) (201)
Bisoprolol Delays Progression Towards Right Heart Failure in Experimental Pulmonary Hypertension (2012) (200)
Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology (2018) (191)
Increased Regional Myocardial Stiffness of the Left Ventricle During Pacing‐induced Angina in Man (1983) (191)
Myocardial Energetics and Efficiency: Current Status of the Noninvasive Approach (2007) (188)
Transstenotic coronary pressure gradient measurement in humans: in vitro and in vivo evaluation of a new pressure monitoring angioplasty guide wire. (1993) (184)
Paracrine coronary endothelial control of left ventricular function in humans. (1995) (183)
Left ventricular torsion: an expanding role in the analysis of myocardial dysfunction. (2009) (183)
Sarcomeric dysfunction in heart failure. (2008) (178)
Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. (1999) (173)
Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species. (2007) (170)
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2020) (158)
Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients. (2007) (155)
Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of Cardiology (2018) (155)
Heart failure with preserved ejection fraction: uncertainties and dilemmas (2015) (136)
NO and cardiac diastolic function. (1999) (127)
Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening (2018) (126)
Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart (2010) (124)
Doppler Echocardiography Yields Dubious Estimates of Left Ventricular Diastolic Pressures (2009) (119)
Altered Left Ventricular Diastolic Properties During Pacing‐Induced Ischemia in Dogs with Coronary Stenoses: Potentiation by Caffeine (1982) (119)
The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction (2013) (118)
Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure. (2010) (113)
Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin (2019) (109)
Effect of early‐onset preeclampsia on cardiovascular risk in the fifth decade of life (2017) (107)
Biomarkers of heart failure with normal ejection fraction: a systematic review (2013) (107)
Deficient Acceleration of Left Ventricular Relaxation During Exercise After Heart Transplantation (1992) (107)
Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: altered left ventricular loading or improved muscle inactivation? (1983) (103)
Different effects of two types of ischemia on myocardial systolic and diastolic function. (1985) (103)
Molecular and Cellular Basis for Diastolic Dysfunction (2012) (99)
Absence of Thrombospondin-2 Causes Age-Related Dilated Cardiomyopathy (2009) (96)
Effects of mechanical left ventricular unloading by impella on left ventricular dynamics in high‐risk and primary percutaneous coronary intervention patients (2010) (95)
Left-ventricular remodeling after myocardial infarction is associated with a cardiomyocyte-specific hypothyroid condition. (2011) (95)
Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine. (1980) (92)
Peroxynitrite-induced alpha-actinin nitration and contractile alterations in isolated human myocardial cells. (2005) (92)
Circulating ACE2 activity correlates with cardiovascular disease development (2016) (92)
SIH--a novel lipophilic iron chelator--protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death. (2005) (89)
Heart failure and cognitive function in the general population: the Hoorn Study (2011) (86)
Nitric oxide's role in the heart: control of beating or breathing? (2004) (83)
Reduction of infarct size by intravenous injection of uncultured adipose derived stromal cells in a rat model is dependent on the time point of application. (2011) (82)
Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction. (2018) (82)
Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies (2007) (80)
Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium. (2006) (80)
Understanding heart failure with preserved ejection fraction: where are we today? (2016) (79)
How are cytokines activated in heart failure? (1999) (78)
Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart. (2009) (77)
Pulmonary embolism causes endomyocarditis in the human heart (2007) (75)
Myocardial stress and hypertrophy: a complex interface between biophysics and cardiac remodeling. (2013) (69)
Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload (2011) (68)
Myofilament dysfunction in cardiac disease from mice to men (2008) (68)
Left ventricular diastolic dysfunction and myocardial stiffness in diabetic mice is attenuated by inhibition of dipeptidyl peptidase 4. (2014) (66)
The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature (2010) (64)
Circulating white blood cells and platelets amplify oxidative stress in heart failure (2008) (61)
Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction. (2009) (61)
Does myocardial fibrosis hinder contractile function and perfusion in idiopathic dilated cardiomyopathy? PET and MR imaging study. (2006) (57)
Comparative Effects of Pacing‐Induced and Balloon Coronary Occlusion Ischemia on Left Ventricular Diastolic Function in Man (1991) (57)
Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome (2016) (56)
Comparative Effects of Ischemia and Hypoxemia on Left Ventricular Systolic and Diastolic Function in Humans (1993) (56)
Molecular determinants of heart failure with normal left ventricular ejection fraction. (2009) (56)
NOX5 expression is increased in intramyocardial blood vessels and cardiomyocytes after acute myocardial infarction in humans. (2012) (55)
Pro-inflammatory cytokines and endothelium-dependent vasodilation in the forearm. Serial assessment in patients with congestive heart failure. (1998) (54)
The Role of Nitric Oxide in the Failing Heart (2001) (53)
Advantages of deformation indices over systolic velocities in assessment of longitudinal systolic function in patients with heart failure and normal ejection fraction (2011) (52)
The cardiac endothelium: cardioactive mediators. (1996) (52)
Intravenous clusterin administration reduces myocardial infarct size in rats (2010) (51)
Dobutamine enhances cardiodepressant effects of receptor-mediated coronary endothelial stimulation. (1997) (50)
Myofilament degradation and dysfunction of human cardiomyocytes in Fabry disease. (2008) (49)
Transcriptional and posttranslational modifications of titin: implications for diastole. (2008) (49)
From Systemic Inflammation to Myocardial Fibrosis (2021) (48)
Myocardial titin and collagen in cardiac diastolic dysfunction: partners in crime. (2013) (47)
Myocardial cytokine gene expression is higher in aortic stenosis than in idiopathic dilated cardiomyopathy (2005) (46)
Effects of aging on left atrioventricular coupling and left ventricular filling assessed using cardiac magnetic resonance imaging in healthy subjects. (2007) (45)
Left ventricular contractile effects of inducible nitric oxide synthase in the human allograft. (1997) (44)
The failing diabetic heart: Focus on diastolic left ventricular dysfunction (2009) (44)
Vitamin D in Relation to Myocardial Structure and Function after Eight Years of Follow-Up: The Hoorn Study (2012) (44)
A refined radio-telemetry technique to monitor right ventricle or pulmonary artery pressures in rats: a useful tool in pulmonary hypertension research (2007) (43)
The influence of endothelium-derived nitric oxide on myocardial contractile function. (1995) (42)
Shared biomarkers between female diastolic heart failure and pre‐eclampsia: a systematic review and meta‐analysis (2017) (40)
More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease (2010) (40)
Matrix, cytoskeleton, or myofilaments: which one to blame for diastolic left ventricular dysfunction? (2005) (39)
Inhibition of type 2A secretory phospholipase A2 reduces death of cardiomyocytes in acute myocardial infarction (2009) (39)
Rationale and application of coronary transstenotic pressure gradient measurements. (1994) (38)
Unfolding Discoveries in Heart Failure. (2020) (38)
Culprit Mechanism(s) for Exercise Intolerance in Heart Failure With Normal Ejection Fraction. (2010) (37)
Cardioprotection Via Activation of Protein Kinase C-&dgr; Depends on Modulation of the Reverse Mode of the Na+/Ca2+ Exchanger (2006) (35)
Nitric oxide and cardiac contractility in human heart failure: time for reappraisal. (2001) (35)
Deteriorating glucose tolerance status is associated with left ventricular dysfunction--the Hoorn Study. (2008) (34)
Cyclooxygenase-2 inhibitors enhance shear stress-induced platelet aggregation. (2006) (34)
Cardiometabolic Syndrome and Increased Risk of Heart Failure (2016) (34)
Contractile arrest reveals calcium-dependent stimulation of SERCA2a mRNA expression in cultured ventricular cardiomyocytes. (2004) (34)
Quantification of diastolic dysfunction via the age dependence of diastolic function - impact of insulin resistance with and without type 2 diabetes. (2015) (32)
Beneficial Effects of Nitric Oxide on Cardiac Diastolic Function: 'The Flip Side of the Coin' (2000) (32)
MicroRNA 214 Is a Potential Regulator of Thyroid Hormone Levels in the Mouse Heart Following Myocardial Infarction, by Targeting the Thyroid-Hormone-Inactivating Enzyme Deiodinase Type III (2016) (31)
Inhibition of Rho-ROCK signaling induces apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippase. (2010) (30)
Slightly elevated B‐type natriuretic peptide levels in a non‐heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the Hoorn Study (2010) (29)
H9c2 cardiomyoblasts produce thyroid hormone. (2008) (28)
Early-onset preeclampsia predisposes to preclinical diastolic left ventricular dysfunction in the fifth decade of life: An observational study (2018) (28)
From comorbidities to heart failure with preserved ejection fraction: a story of oxidative stress (2015) (28)
Ventricular myocarditis coincides with atrial myocarditis in patients. (2014) (27)
Investigating a biomarker‐driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C‐terminal propeptide of procollagen type I (DROP‐PIP trial) (2018) (27)
Increased local delivery of antagomir therapeutics to the rodent myocardium using ultrasound and microbubbles. (2016) (27)
Endomyocardial nitric oxide synthase and the hemodynamic phenotypes of human dilated cardiomyopathy and of athlete's heart. (2002) (26)
Prospective Associations of B-Type Natriuretic Peptide With Markers of Left Ventricular Function in Individuals With and Without Type 2 Diabetes (2012) (26)
Treatment of Heart Failure With Normal Ejection Fraction (2010) (26)
Atrial fibrillation coincides with the advanced glycation end product N(ε)-(carboxymethyl)lysine in the atrium. (2015) (25)
H2FPEF Score: At Last, a Properly Validated Diagnostic Algorithm for Heart Failure With Preserved Ejection Fraction (2018) (24)
Ultrasound and microbubble-targeted delivery of therapeutic compounds (2009) (24)
A Multiorgan Roadmap (2016) (24)
Deliberating the Diagnostic Dilemma of Heart Failure With Preserved Ejection Fraction. (2020) (23)
Independent Associations of Glucose Status and Arterial Stiffness With Left Ventricular Diastolic Dysfunction (2012) (23)
RhoA-ROCK signaling is involved in contraction-mediated inhibition of SERCA2a expression in cardiomyocytes (2009) (23)
The effect of biological DMARDs on the risk of congestive heart failure in rheumatoid arthritis: a systematic review (2018) (23)
Cytokines and heart failure. (2000) (23)
NOX2, p22phox and p47phox are Targeted to the Nuclear Pore Complex in Ischemic Cardiomyocytes Colocalizing with Local Reactive Oxygen Species (2011) (22)
Myocardial Contractile Effects of Nitric Oxide (2004) (22)
Diastolic and systolic heart failure: Different stages or distinct phenotypes of the heart failure syndrome? (2009) (22)
A Novel Electrocardiographic Index for the Diagnosis of Diastolic Dysfunction (2013) (22)
Diastolic dysfunction is initiated by cardiomyocyte impairment ahead of endothelial dysfunction due to increased oxidative stress and inflammation in an experimental prediabetes model. (2019) (21)
Nitric oxide: the missing lusitrope in failing myocardium. (2008) (20)
Endothelial control of vascular and myocardial function in heart failure (1994) (19)
Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure) (2020) (19)
Novel strategies in diastolic heart failure (2010) (19)
Myocardial fibrosis blunts nitric oxide synthase-related preload reserve in human dilated cardiomyopathy. (2003) (18)
&agr;-B Crystallin Reverses High Diastolic Stiffness of Failing Human Cardiomyocytes (2017) (18)
Do Existing Definitions Identify Subgroup Phenotypes or Reflect the Natural History of Heart Failure With Preserved Ejection Fraction? (2019) (18)
Transitioning from Preclinical to Clinical Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach (2020) (18)
Ultrasound and microbubble-induced local delivery of MicroRNA-based therapeutics. (2015) (18)
The future diagnosis of heart failure with normal ejection fraction: less imaging, more biomarkers? (2011) (17)
Pathophysiological rationale and diagnostic targets for diastolic stress testing (2015) (16)
Arterial Remodeling and Dysfunction in the ZSF1 Rat Model of Heart Failure With Preserved Ejection Fraction. (2019) (16)
Heart failure with preserved ejection fraction: a nephrologist-directed primer (2017) (15)
Early NADPH oxidase-2 activation is crucial in phenylephrine-induced hypertrophy of H9c2 cells. (2014) (15)
Polishing the diastolic dysfunction measurement stick. (2008) (15)
Stretch-induced compliance: a novel adaptive biological mechanism following acute cardiac load (2018) (14)
Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review (2020) (14)
Paracrine coronary endothelial modulation of diastolic left ventricular function in man: implications for diastolic heart failure. (1996) (14)
Myocardial contractile effects of L-arginine in the human allograft. (1997) (14)
The dialogue between diabetes and diastole (2009) (14)
The Basement Membrane of Intramyocardial Capillaries Is Thickened in Patients with Acute Myocardial Infarction (2009) (13)
Cellular mechanisms for diastolic dysfunction in the human heart. (2012) (13)
Myocardial contractile effects of nitric oxide. (2002) (13)
Effects of verapamil on regional myocardial diastolic function in pacing-induced ischemia in dogs. (1986) (12)
Systolic Time Intervals: A Valuable Parameter of Thyroid Function (1980) (11)
Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA‐HFpEF trial (2020) (11)
Normal resting pulmonary artery wedge pressure: a diagnostic trap for heart failure with preserved ejection fraction (2015) (11)
Impact of Comorbidities on Myocardial Remodeling and Dysfunction In Heart Failure with Preserved Ejection Fraction (2014) (11)
Molecular and pathophysiological links between heart failure with preserved ejection fraction and type 2 diabetes mellitus (2018) (11)
Myocardial infarction induces atrial inflammation that can be prevented by C1-esterase inhibitor (2016) (11)
Low-grade inflammation and endothelial dysfunction explain the association between retinopathy and left ventricular ejection fraction in men: an 8-year follow-up of the Hoorn Study. (2014) (10)
Natriuretic peptides to probe haemodynamic overload in hypertrophic cardiomyopathy. (2001) (10)
Phosphodiesterase‐5 inhibition in heart failure with preserved ejection fraction: trading therapy for prevention (2017) (10)
Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score (2021) (10)
Sex differences in circulating proteins in heart failure with preserved ejection fraction (2020) (9)
Clinical Cardiology: Current Practice Guidelines (2014) (9)
Iconoclasts topple adaptive myocardial hypertrophy in aortic stenosis. (2005) (9)
Genome-Wide Identification of Epigenetic Hotspots Potentially Related to Cardiovascular Risk in Adult Women after a Complicated Pregnancy (2016) (9)
CrossTalk opposing view: The late sodium current is not an important player in the development of diastolic heart failure (heart failure with a preserved ejection fraction) (2014) (8)
Failure of Inactivation of Hypertrophied Myocardium: A Cause of Impaired Left Ventricular Filling in Hypertrophic Cardiomyopathy and Aortic Stenosis (1987) (8)
Inhibition of type 2 A secretory phospholipase A 2 reduces death of cardiomyocytes in acute myocardial infarction (2009) (8)
Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction (2020) (8)
Failure of myocardial inactivation: a clinical assessment in the hypertrophied heart. (1992) (8)
Microvascular Paradigm in Heart Failure With Preserved Ejection Fraction: A Quest for Proof of Concept (2017) (7)
Lymphocytes infiltrate the quadriceps muscle in lymphocytic myocarditis patients: a potential new diagnostic tool. (2014) (6)
Invasive Evaluation of Diastolic Left Ventricular Dysfunction (2008) (6)
Does dobutamine prevent the rise in left ventricular filling pressures observed during exercise after heart transplantation? (1995) (6)
Phenotypic Persistence in Heart Failure With Preserved Ejection Fraction (2019) (6)
Heart failure with preserved ejection fraction: current status and challenges for the future (2016) (6)
Turning the Retrospectroscope on Heart Failure With Preserved Ejection Fraction. (2016) (5)
H 9 c 2 cardiomyoblasts produce thyroid hormone (2008) (5)
Adhesion molecules in early adulthood predict heart failure with preserved ejection fraction at older age. (2020) (4)
p47phox-Dependent Reactive Oxygen Species Stimulate Nuclear Translocation of the FoxO1 Transcription Factor During Metabolic Inhibition in Cardiomyoblasts (2018) (4)
Diastolicdysfunction. Echocardiographic detection, etiology and therapy (2016) (4)
Ancient Gunpowder and Novel Insights Team Up Against Heart Failure With Preserved Ejection Fraction. (2015) (4)
H 2 FPEF Score (2018) (4)
Increased nitrosative/oxidative stress lowers myocardial protein kinase G activity in heart failure with preserved ejection fraction (2013) (4)
Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy (1999) (4)
METABOLIC COMORBIDITIES ASSOCIATED WITH ENDOTHELIAL INFLAMMATION AND REDUCED NO-BIOAVALABILITY AS A NOVEL PARADIGM FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION (2014) (3)
Abstract 17471: The Obese Zsf1 Rat as a New Model of Heart Failure with Preserved Ejection Fraction Accompanying the Metabolic Syndrome (2012) (3)
RELATIVE IMPORTANCE OF TITIN AND COLLAGEN FOR MYOCARDIAL STIFFNESS IN METABOLIC RISK-INDUCED HEART FAILURE WITH PRESERVED EJECTION FRACTION (2013) (3)
Racial Tension in Hypertension: Divergent Effects of African and European Ancestry on Cardiac Remodeling. (2017) (3)
Myocardial Microvascular In fl ammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction (2016) (3)
Cardioprotection Via Activation of Protein Kinase C- (cid:1) Depends on Modulation of the Reverse Mode of the Na (cid:2) /Ca Exchanger (2006) (3)
Intracoronary pressure measurements with a 0.015″ fluid-filled angioplasty guide wire (1994) (3)
66: Higher prevalence of diastolic dysfunction in women who have had a decade ago early onset preeclampsia (2017) (2)
Coronary Artery Disease and Diastolic Left Ventricular Dysfunction (2008) (2)
Increased NADPH oxidase mediated superoxide production in human heart failure: Potential role in left ventricular dysfunction (2002) (2)
Abstract 3156: Protein Kinase G Corrects High Cardiomyocyte Resting Tension in Diastolic Heart Failure (2007) (2)
Heart Failure Peripartum Cardiomyopathy as a Part of Familial Dilated Cardiomyopathy (2010) (2)
Abstract 11681: Increased Nitrosative/Oxidative Stress Lowers Myocardial Protein Kinase G Activity in Heart Failure with Preserved Ejection Fraction (2011) (2)
New statement of the European Society of Cardiology on diagnosing diastolic heart failure: what are the key messages. (2008) (2)
[Heart failure with preserved ejection fraction: Diastolic heart failure]. (2012) (2)
Intravenous clusterin administration reduces myocardial infarct size in rats: CLUSTERIN ADMINISTRATION REDUCES INFARCT SIZE (2010) (2)
Chronic Treatment With Low-Dose Bisoprolol Improves Survival And Cardiac Function In Experimental Pulmonary Arterial Hypertension (2010) (1)
Diastole Tracks Cardiometabolic Risk. (2018) (1)
Abstract 3156: Myofilament Dysfunction in Human Cardiomyocytes with Fabry Disease (2006) (1)
Increased nitrosative/oxidative stress lowers myocardial protein kinase G activity in heart failure with preserved ejection fraction (2013) (1)
Myocardial Inducible Nitric Oxide Synthase and Left Ventricular Performance in the Human Heart (1999) (1)
485 Monocrotaline‐induced pulmonary hypertension induces septum and left ventricular remodeling in mice (2005) (1)
Border Disputes Between Heart Failure Phenotypes. (2022) (1)
Exercise-Induced Diastolic Left Ventricular Dysfunction after Heart Transplantation (1998) (1)
Iconographies supplémentaires de l'article : 66: Higher prevalence of diastolic dysfunction in women who have had a decade ago early onset preeclampsia (2017) (0)
Abstract 4864: Distinct Myocardial Effects of Beta-Blocker Therapy in Heart Failure with Normal and Reduced Left Ventricular Ejection Fraction (2008) (0)
Poster Session 3 (2012) (0)
Editorial Board (2010) (0)
CHAPTER 7 Model for the Prediction of Incident Heart Failure in the General Population : the Hoorn Study Heart Failure Risk Score (2011) (0)
Diabetes Mellitus High-Energy Phosphate Metabolism in Patients With Well-Controlled Type 2 Metabolism Without Affecting Cardiac Triglyceride Accumulation and Pioglitazone Improves Cardiac Function and Alters Myocardial Substrate (2009) (0)
Sex differences in circulating proteins in heart failure with preserved ejection fraction (2020) (0)
Abstract 1468: Opposite Effects Of Chronic Beta-blocker Therapy On Myofilament Function In Heart Failure With Reduced Or Normal Left Ventricular Ejection Fraction (2007) (0)
Abstract 1463: Titin Isoform Phosphorylation in Failing Human Myocardium (2007) (0)
Saturday, 17 July 2010 (2010) (0)
8 Ventricular myocarditis coincides with atrial myocarditis in humans * (2015) (0)
Lusitropic function of the cardiac allograft: Loading and inactivation dependent effects (1991) (0)
Abstract 1953: Myocardial Titin Isoform Phosphorylation in Diastolic Heart Failure (2007) (0)
Editorial board (1993) (0)
Empagliflozin for heart failure with preserved ejection fraction: targeting cardiac endothelial cell-cardiomyocyte interaction (2018) (0)
E ndomyocardial nitric oxide synthase and the hemodynamic phenotypes of human dilated cardiomyopathy and of athlete’s heart (2002) (0)
Diastolic Function of the NonWing Human Left Ventricle (2016) (0)
Response to Letter Regarding Article, "Peripartum Cardiomyopathy as a Part of Familial Dilated Cardiomyopathy" (2011) (0)
P103Impact of diabetes mellitus on myofilaments phosphorylation and calcium sensitivity is aortic stenosis patients (2014) (0)
cardIoselectIVe beta- blocker tHeraPy ImProVes surVIVal and cardIac FunctIon In exPerImental Pulmonary HyPertensIon (2010) (0)
[Diastolic left ventricular dysfunction related with exercise in heart failure]. (1998) (0)
Sunday, 18 July 2010 (2010) (0)
The future diagnosis of heart failure with normal ejec 8 on frac 8 on : less imaging , more biomarkers ? by Constan 8 jn (2017) (0)
Postextrasystoli c Potentiation Worsens FastFilling oftheHypertrophied LeftVentricle inAortic Stenosis and Hypertrophic Cardiomyopathy (1988) (0)
67: Increased cardiovascular risk 9-16 years after early onset preeclampsia (2017) (0)
Reduced myocardial contractile effects of nitric oxide after heart transplantation: Implications for diastolic dysfunction of the cardiac allograft (1996) (0)
Abstract 13606: Patients With Lymphocytic Myocarditis Have Increased Lymphocytes in the Skeletal Muscle: A New Diagnostic Tool (2013) (0)
Abstract 17857: Diastolic Destiffening of Failing Human Cardiomyocytes (2010) (0)
P5650Cyclic guanosine monophosphate enhancing therapeutic strategy for heart failure with preserved ejection fraction (cGETS study): effects on cardiac dysfunction and remodeling (2018) (0)
1 General IntroductIon Pulmonary arterIal HyPertensIon and rIGHt Heart FaIlure (2010) (0)
Abstract 3151: Stiffness of Hypertrophied Cardiomyocytes Differs in Aortic Stenosis and Arterial Hypertension (2006) (0)
Calcium blockade - nifedipine in the treatment of hypertrophic cardiomyopathy (1985) (0)
HYPERTROPHIC CARDIOMYOPATHY Effects of long-term treatment with amiodarone on exercise hemodynamics and left ventricular relaxation in patients with hypertrophic cardiomyopathy (2005) (0)
Abstract 16773: Associations between Heart Failure and Cognitive Function (2010) (0)
Abstract 17254: Diabetes Mellitus Significantly Impacts Left Ventricular Myocardial Structure and Function in Aortic Stenosis Before Valve Replacement (2010) (0)
From hemodynamic principles to clinical management (1991) (0)
Abstract 11716: Statins Favourably Affect Cardiomyocyte Hypertrophy and Myocardial Protein Kinase G Activity in Heart Failure with Preserved Ejection Fraction (2011) (0)
Nitric Oxide and Cardiac Contraction: Clinical Studies (2020) (0)
Increased regional myocardial stiffness of the left ventricle during angina pectoris (1982) (0)
Abstract 17754: Antioxidants Lower Diastolic Stiffness of Failing Human Cardiomyocytes (2010) (0)
stimulation for dilated cardiomyopathy Left-to-right systolic ventricular interaction in patients undergoing biventricular (2010) (0)
Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction (2023) (0)
Prevalence and correlates of left ventricular diastolic dysfunction in a community-based elderly female population in China (2013) (0)
Abstract 11253: Inhibition of Dipeptidyl Peptidase IV Improves Left Ventricular Compliance in Obese Diabetic Mice (2012) (0)
L-arginine and dobutamine modity myocardial contractile response to receptor-mediated coronary endothelial stimulation after cardiac transplantation (1996) (0)
Boosting small heat shock proteins lowers cardiomyocyte passive stiffness in experimental heart failure with preserved ejection fraction (2018) (0)
Abstract 17888: Heart Failure Alters Slack Sarcomere Length and Z-disc width in Single Human Cardiomyocytes (2010) (0)
Effects of dipeptidyl peptidase IV inhibition on left ventricular compliance in obese mice with type II diabetes (2013) (0)
Abstract 17690: Thyroid Hormone-Regulated Cardiac MicroRNAs May Suppress Pathological Hypertrophic Signaling (2014) (0)
Cardiac induction of type III deiodinase in human ischemic heart disease (2012) (0)
Abstract 3754: Fibrosis, AGEs or Stiff Cardiomyocytes: Which One to Blame for the High Diastolic Stiffness of the Diabetic Heart? (2006) (0)
Abstract 3577: Titin-Actin Interaction Contributes to High Resting Tension of Failing Human Cardiomyocytes (2009) (0)
Reply: Diabetes and Heart Failure: Are We in the Right Direction to Find the Right Morsel for Success? (2018) (0)
Cyclic Guanosine Monophosphate Enhancing Therapeutic Strategy for HFpEF (cGETS study): effects on cardiac dysfunction and remodeling (2018) (0)
Rebuttal from Zoltán Papp, Attila Borbély and Walter J. Paulus (2014) (0)
Abstract 4329: Myocardial Protein Kinase G Activity Differs in Heart Failure with Normal and Reduced Ejection Fraction (2008) (0)
p47phox-Dependent Reactive Oxygen Species Stimulate Nuclear Translocation of the FoxO1 Transcription Factor During Metabolic Inhibition in Cardiomyoblasts (2018) (0)
Stenosis Through Altered Myocardial Structure and Cardiomyocyte Stiffness Diabetes Mellitus Worsens Diastolic Left Ventricular Dysfunction in Aortic (2012) (0)
Diastolic Pressures Doppler Echocardiography Yields Dubious Estimates of Left Ventricular (2011) (0)
Left Ventricular Relaxation (2005) (0)
Alterations in Ventricular Function (2020) (0)
Prospective association of B-type natriuretic peptide with left ventricular systolic and diastolic function in individuals with and without type 2 diabetes - the Hoorn study (2010) (0)
592 Myocardial contractile activity induces opposite changes in SERCA2a and ANF transcription through activation of RhoA‐serum response factor signaling (2005) (0)
Chronic Aortic Regurgitation (2009) (0)
yclooxygenase-2 Inhibitors Enhance hear Stress-Induced Platelet Aggregation (2006) (0)
B-Type Natriuretic Peptide Is Associated with Left Ventricular Structure, but Not Function, Especially in Women with Type 2 Diabetes-The Hoorn Study (2009) (0)
493-P: Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Uremic Serum and Restored by Empagliflozin (2020) (0)
Paracrine modulation by vascular and endocardial endothelium of coronary vasomotor tone and myocardial performance (1995) (0)
"Diastolic Heart Failure Is Clearly a Consequence of Affluence and 'Overindulgence' in Western Countries, and There Is a Suspicion That It Is Correctable and Reversible" (2012) (0)
Abstract 4867: Myocardial Effects of Beta-Blocker Therapy in the Failing Diabetic Heart (2008) (0)
High expression of inducible nitric oxide synthase in athlete's heart (2000) (0)
CORONARY OCCLUSION (1949) (0)
Abstract 1876: Beta-blocker Therapy alters Myofilament Function in Patients with Congestive Heart Failure (2006) (0)
Poster session 3 (2001) (0)
Limited Accuracy of the New ASE/EACVI-Algorithm for Heart Failure With Preserved Ejection Fraction (VeeDIA-Study I) (2017) (0)
112 Thrombospondin‐2 guards against aging‐related cardiomyopathy by increasing beta 1‐integrin mediated signaling (2008) (0)
Haemodynamic evaluation of diastolic abnormalities in hypertrophic cardiomyopathy (1985) (0)
Paracrine modulation of coronary vasomotor tone and myocardial performance by vascular and endocardial endothelium. (1995) (0)
Left-sided cardiac deterioration occurs especially in women with impaired glucose metabolism - an 8-year follow-up of The Hoorn Study (2009) (0)
Patients With Lymphocytic Myocarditis Have Increased Lymphocytes in the Skeletal Muscle: A New Diagnostic Tool (2013) (0)
Arterial stiffness is prospectively associated with left ventricular diastolic function in individuals with and without type 2 diabetes - the Hoorn study (2010) (0)
5 Cardio-Selective Beta-Blocker Therapy Improves Survival and Cardiac Function in Experimental Pulmonary Hypertension (2010) (0)
Abstract 2798: Myocardial Titin Isoform Expression in Concentric and Eccentric Left Ventricular Remodeling (2007) (0)
Effects of verapamil and caffeine on regional myocardial diastolic function in pacing-induced ischemia in dogs (1982) (0)
Editorial Board (2011) (0)
From Comorbidi 0 es to Heart Failure with Preserved Ejec 0 on Frac 0 on : A Story of Oxida 0 ve Stress (2016) (0)
Plasma natriuretic peptides relate to distinct patterns of left ventricular dysfunction in chronic HFpEF (2018) (0)
279 Cell determinants of myocardial dysfunction in fabry disease cardiomyopathy (2006) (0)
Isovolumic relaxation kinetics of the hypertrophied left ventricle in man (1991) (0)
Induction of Endocytosis and Pore Formation Ultrasound and Microbubble-Targeted Delivery of Macromolecules Is Regulated (2009) (0)
775 Higher myocardial cytokine gene expression in aortic stenosis than in idiopahic dilated cardiomyopathy (2003) (0)
Comparative Effects of Ischemia and Hypoxemia on Left Ventricular Diastolic Function in Humans (1994) (0)
Abstract 3746: Circulating White Blood Cells Amplify Oxidative Stress in Congestive Heart Failure (2006) (0)
594 Inactivation of GSK3b results in nuclear accumulation of NFATc4 but is not involved in GATA‐4 dependent stimulation of SERCA2a transcription (2005) (0)
DISTINCT MECHANISMS FOR DIASTOLIC DYSFUNCTION IN DIABETES MELLITUS AND PRESSURE-OVERLOAD (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Walter j. Paulus?

Walter j. Paulus is affiliated with the following schools:

Walter j. Paulus's Academic­Influence.com Rankings

Why Is Walter j. Paulus Influential?

Walter j. Paulus's Published Works

Published Works

What Schools Are Affiliated With Walter j. Paulus?

Walter j. Paulus's AcademicInfluence.com Rankings